摘要
目的:临床观察和评估替托尼定治疗急性痉挛性肌痛的有效性和安全性。方法:急性痉挛性肌痛60例,男性39例,女性21例,年龄39±s9a。随机均分为3组,分别服用替托尼定1mg,tid,替托尼定1mg加双氯芬酸25mg,tid,双氯芬酸25mg,tid,共14d,观察在接触时、运动时、休息时及夜间在服药前后疼痛程度的变化;并记录不良反应。结果:3组服药d4的总有效率分别为81%,83%和65%。前2组的不良反应为轻微的嗜睡(10%)。结论:替托尼定较双氯芬酸更快、更有效地解除痉挛性肌痛(P<0.05),合适剂量为3mg/d。
AIM: To evaluate clinically the efficacy and tolerability of tizanidine in the treatment of acute painful muscle spasms. METHODS: Sixty patients (M 39, F 21, age 39±s 9 a) with acute painful muscle spasms were randomly and equally divided into 3 groups. Tizanidine (3 mg/d), tizanidine (3 mg/d) plus diclofenac (75 mg/d), and diclofenac (75 mg/d) were respectively given orally to each of the groups for 14 d. The severities of pain on palpation, during movement, at rest and at night were evaluated before and after administrations of the drugs, and the adverse reactions were recorded. RESULTS: The effective rates on d 4 after administration in 3 groups were 81%, 83% and 65%, respectively. The adverse reactions of tizanidine recorded were drowsinesses (10%) which were mild and transient. CONCLUSION: Tizanidine relieves the acute painful spasms more effectively and quicklier than diclofenac does (P<0.05). The suitable dosage for patients is 3 mg daily.
出处
《新药与临床》
CSCD
北大核心
1997年第5期281-283,共3页